Use of 5-fluorouracil, epirubicin and mitomycin C (FEM) as adjuvant therapy in node-positive, radically-resected gastric cancer patients: survey of a general hospital experience.

Saved in:
Bibliographic Details
Title: Use of 5-fluorouracil, epirubicin and mitomycin C (FEM) as adjuvant therapy in node-positive, radically-resected gastric cancer patients: survey of a general hospital experience.
Authors: Caffo O; Department of Medical Oncology, S. Chiara Hospital, Largo Medaglie D'Oro, 38100 Trento, Italy., Ambrosini G, Amichetti M, Brugnara S, Graiff C, Robbiati SF, Galligioni E
Source: Oncology reports [Oncol Rep] 1998 Nov-Dec; Vol. 5 (6), pp. 1465-9.
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print Cited Medium: Print ISSN: 1021-335X (Print) Linking ISSN: 1021335X NLM ISO Abbreviation: Oncol Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1021-335X
DOI:10.3892/or.5.6.1465